Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Notable Analyst Rating Changes 04/04: (SBUX) (JOY) (CIEN) Upgraded; (ALLT) (MCD) (IBM) Downgraded
-
Cantor Fitzgerald Starts Celldex Therapeutics (CLDX) at Buy; Valuation Not Reflecting Depth
-
Cantor Fitzgerald Starts Celgene (CELG) at Buy; Pipeline is Considerable
-
Cantor Fitzgerald Starts BrandyWine (BDN) at Buy; Growth Through Acquisitions
-
Cantor Fitzgerald Starts United Natural Foods (UNFI) at Sell; Shares Already Discounting Significant Benefits
-
Cantor Fitzgerald Starts Kilroy Realty (KRC) at Sell; Robust Fundamentals, But Shares Fully Valued
-
Cantor Fitzgerald Starts Parkway Properties (PKY) at Buy; Confidence In New, But Seasoned Management Team
-
Cantor Fitzgerald Starts Boston Properties Inc. (BXP) at Buy; Growth in Portfolio Supports Value
-
Cantor Fitzgerald Starts SL Green Realty (SLG) at Buy; Growth Through JV's and Retail Acquisitions
-
Cantor Fitzgerald Starts Tessera Technologies (TSRA) at Buy; Emerging Growth Prospects & Potential Litigation Wins
-
Cantor Fitzgerald Starts Cousins Properties (CUZ) at Hold; Switching Strategies
-
Cantor Fitzgerald Starts HCA Holdings (HCA) at Buy; A Room Full of Possibilities
-
Cantor Fitzgerald Downgrades Real Goods Solar (RSOL) to Hold; Weak Qtr and Disappointing Guidance
-
Cantor Fitzgerald Starts Warner Chilcott (WCRX) at Buy; Few Concerns, But Value Of Business Being Overlooked
-
Cantor Fitzgerald Starts Endo Pharma (ENDP) at Buy, $50 Price Target
-
Cantor Fitzgerald Starts Spartan Stores (SPTN) at Hold, $18 Price Target
-
Cantor Fitzgerald Cuts Eagle Bulk Shipping (EGLE) to Sell
-
Cantor Fitzgerald Maintains a 'Hold' on Dendreon (DNDN); Understanding Where A Catalyst For Valuation Expansion Will Come From
-
Cantor Fitzgerald Starts Health Management (HMA) at Hold; Good Strategy, But Waiting For Recovery
-
Cantor Fitzgerald Starts Community Health (CYH) at Hold; Integration Pressure Near-Term, But Long-Term Solid
-
Cantor Fitzgerald Starts AmSurg (AMSG) at Hold; Growth Slowed, Outlook Remains Uncertain
-
Cantor Fitzgerald Starts Lifepoint Holdings (LPNT) at Buy; Duke JV Enhances Reputation and Opens Attractive New Markets
-
Cantor Fitzgerald Starts Vanguard Health Systems (VHS) at Buy; Expecting Better Results Over Next Two Yrs
-
Cantor Fitzgerald Starts Riverbed Technology (RVBD) at Buy; Still See Upside Despite Recent Recovery
-
Cantor Fitzgerald Starts Datalink Corporation (DTLK) at Buy; Sitting At The Sweet Spot
-
Cantor Fitzgerald Starts QLogic (QLGC) at Hold; Plenty of Cash, But Growth Challenges Remain
-
Cantor Fitzgerald Starts Brocade (BRCD) at Hold, $6.50 Price Target
-
Cantor Fitzgerald Starts F5 Networks (FFIV) at Hold; Uncontested in Core Market, Untested Outside
-
Cantor Fitzgerald Starts EMC (EMC) at Hold; Fully Valued 'Til 2013 Comes into Focus
-
Cantor Fitzgerald Starts NetApp (NTAP) at Hold; Bumpy N-T Obsure Potentially Attractive FY13
-
Cantor Fitzgerald Starts Cisco (CSCO) at Buy; Valuation Yet to Catch Up to Improving Execution
-
Cantor Fitzgerald Starts Juniper Networks (JNPR) at Hold; Risk Before The Reward
-
Cantor Fitzgerald Starts Emulex (ELX) at Buy; Overhang Nearing End, Romley Ahead
-
Cantor Fitzgerald Starts Coverage on Hotel Sector: MAR, WYN, AHT at Buy, H, HOT, HST at Hold
-
Q4 Preview: Kroger (KR) Analysts Skeptical as Inflation Could Weigh on Volume
-
Cantor Fitzgerald Raises Price Target on Medicis (MRX) But Remains Concerned
-
Cantor Fitzgerald Downgrades Ironwood Pharmaceuticals (IRWD) to Sell; Recommend Taking Profits
-
Cantor Fitzgerald Downgrades Ironwood Pharmaceuticals (IRWD) to Sell
-
Cantor Fitzgerald Raises Price Target on Conceptus (CPTS), Strongly Positioned for Growth
-
Cantor Fitzgerald Starts First Potomac (FPO) at Buy; Government Overhang = Opportunity
-
Cantor Fitzgerald Starts EastGroup Properties (EGP) at Sell; Stable Outlook, yet Valuation Rich
-
Cantor Fitzgerald Starts ProLogis (PLD) at Buy; De-levering Through Private Capital
-
Cantor Fitzgerald Starts STAG Industrial (STAG) at Hold; Grazing Far From the Herd
-
Cantor Fitzgerald Raises Price Target on Skyworks Solutions (SWKS) After Talks with CEO, Notes Co. is Undervalued
-
Cantor Fitzgerald Raises Price Target on Microsemi (MSCC), Sees Earnings Momentum Coming Back
-
Conmed Healthcare Management (CONM) Hires Cantor Fitzgerald to Evaluate Strategic Alternatives
-
Cantor Fitzgerald Starts Mindspeed Technologies (MSPD) at Buy; Small-Cell Crackerjack and Leveraged 4G Play
-
Cantor Fitzgerald Reiterates a 'Buy' on Given Imaging (GIVN); Strong Quarter Sets Stage for Important 2012
-
Cantor Fitzgerald Starts Post Properties (PPS) at Buy; The Southern Bellwether
-
Cantor Fitzgerald Starts Equity LifeStyle Properties (ELS) at Hold; Utilization Trumps Depreciation

